Church & Dwight Co., Inc. (NYSE:CHD) Shares Bought by Captrust Financial Advisors

Captrust Financial Advisors raised its position in Church & Dwight Co., Inc. (NYSE:CHD - Free Report) by 11.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 38,430 shares of the company's stock after purchasing an additional 3,847 shares during the quarter. Captrust Financial Advisors' holdings in Church & Dwight were worth $4,024,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in CHD. Cary Street Partners Financial LLC bought a new position in Church & Dwight in the 4th quarter worth about $153,000. Balyasny Asset Management L.P. acquired a new stake in Church & Dwight in the fourth quarter valued at approximately $15,298,000. Banque Transatlantique SA acquired a new stake in Church & Dwight in the fourth quarter valued at approximately $46,000. Benjamin Edwards Inc. boosted its position in Church & Dwight by 3.6% in the fourth quarter. Benjamin Edwards Inc. now owns 11,713 shares of the company's stock valued at $1,226,000 after buying an additional 411 shares during the last quarter. Finally, BLI Banque de Luxembourg Investments purchased a new stake in Church & Dwight in the fourth quarter valued at approximately $13,251,000. 86.60% of the stock is owned by hedge funds and other institutional investors.

Church & Dwight Stock Performance

Shares of Church & Dwight stock traded down $1.06 on Tuesday, hitting $94.12. The stock had a trading volume of 3,654,975 shares, compared to its average volume of 1,618,063. The stock has a market cap of $23.18 billion, a price-to-earnings ratio of 39.71, a P/E/G ratio of 3.32 and a beta of 0.55. The company has a current ratio of 1.70, a quick ratio of 1.24 and a debt-to-equity ratio of 0.51. Church & Dwight Co., Inc. has a 52-week low of $90.99 and a 52-week high of $116.46. The company's 50 day moving average price is $103.72 and its 200 day moving average price is $105.50.

Church & Dwight (NYSE:CHD - Get Free Report) last announced its earnings results on Thursday, May 1st. The company reported $0.91 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.89 by $0.02. The firm had revenue of $1.47 billion during the quarter, compared to analysts' expectations of $1.52 billion. Church & Dwight had a return on equity of 20.03% and a net margin of 9.58%. The business's revenue was down 2.4% on a year-over-year basis. During the same period in the prior year, the firm earned $0.96 EPS. On average, research analysts anticipate that Church & Dwight Co., Inc. will post 3.7 EPS for the current year.

Church & Dwight Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, June 2nd. Investors of record on Thursday, May 15th will be paid a dividend of $0.295 per share. This represents a $1.18 dividend on an annualized basis and a yield of 1.25%. The ex-dividend date of this dividend is Thursday, May 15th. Church & Dwight's dividend payout ratio is currently 50.64%.

Insider Buying and Selling

In related news, EVP Michael Read purchased 3,000 shares of the business's stock in a transaction dated Friday, May 9th. The stock was acquired at an average price of $92.07 per share, for a total transaction of $276,210.00. Following the acquisition, the executive vice president now directly owns 5,505 shares of the company's stock, valued at $506,845.35. This trade represents a 119.76% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Maynadier Patrick D. De sold 54,510 shares of the firm's stock in a transaction dated Monday, March 10th. The shares were sold at an average price of $115.98, for a total transaction of $6,322,069.80. Following the transaction, the executive vice president now owns 10,497 shares of the company's stock, valued at $1,217,442.06. This trade represents a 83.85% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 80,230 shares of company stock worth $8,903,734 in the last 90 days. Company insiders own 2.00% of the company's stock.

Wall Street Analyst Weigh In

CHD has been the subject of several recent research reports. UBS Group reduced their target price on shares of Church & Dwight from $110.00 to $102.00 and set a "neutral" rating for the company in a report on Friday, May 2nd. Truist Financial boosted their price target on shares of Church & Dwight from $110.00 to $115.00 and gave the stock a "buy" rating in a research report on Monday, February 3rd. Morgan Stanley reduced their target price on shares of Church & Dwight from $110.00 to $100.00 and set an "equal weight" rating on the stock in a research note on Monday, May 5th. Stifel Nicolaus boosted their price target on shares of Church & Dwight from $103.00 to $105.00 and gave the company a "hold" rating in a research note on Monday, February 3rd. Finally, Royal Bank of Canada dropped their target price on Church & Dwight from $105.00 to $100.00 and set a "sector perform" rating for the company in a research report on Friday, May 2nd. Two analysts have rated the stock with a sell rating, eight have given a hold rating and seven have given a buy rating to the company. According to MarketBeat, the stock has an average rating of "Hold" and a consensus target price of $109.13.

Church & Dwight Company Profile

Church & Dwight Co, Inc engages in the development, manufacture, and marketing of household, personal care, and specialty products. It operates through the following segments: Consumer Domestic, Consumer International, Specialty Products Division (SPD), and Corporate. The Consumer Domestic segment offers household products, such as laundry detergents, fabric softener sheets, cat litter, household cleaning products, and personal care products including antiperspirants, oral care products, depilatories, reproductive health products, oral analgesics, nasal saline moisturizers, and dietary supplements.